The purpose of this to is to recruit, follow, and complete the "open-label, phase i study of the safety and pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in infants…
Active Awarded Last action
- Contract number
- 75N94024F00001
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,505,456
Award facts
- Contract value 100% obligated
- $2,505,456.00 Current and potential, with all options
- Completion date 53% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Westat, Inc. has been awarded a cost-plus-fixed-fee delivery order valued at up to $2,505,456 by the National Institutes of Health's National Institute of Child Health and Human Development to complete an open-label Phase I clinical study of the safety and pharmacokinetics of monoclonal antibodies PGT121.414.LS and VRC07-523LS in infants exposed to HIV-1. The purpose of the study is outlined in the original task order solicitation under Westat's $175 million Infectious Disease Research Data Coordination IDIQ vehicle. No set-aside designation was applied to this award. Work will be performed in Potomac, Maryland through February 2029.
Description
The purpose of this to is to recruit, follow, and complete the "open-label, phase i study of the safety and pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in infants exposed to HIV-1."
Quick answers
Who was awarded contract 75N94024F00001?
75N94024F00001 was awarded to Westat, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on March 1, 2024.
How much is contract 75N94024F00001 worth?
The government has obligated $2,505,456 on 75N94024F00001.
Is contract 75N94024F00001 an order under another contract?
Yes. 75N94024F00001 is a delivery order under 75N94023D00001, an indefinite delivery contract.
Was contract 75N94024F00001 competed?
The extent of competition for 75N94024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award